Device
Self monitoring blood glucose
Self monitoring blood glucose is a medical device with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
completed267%
not_yet_recruiting133%
Recent Activity
0 active trials
Showing 3 of 3
completednot_applicable
Utility of Real Time Continuous Glucose Monitoring in the Care of Gestational Diabetes Versus Standard Care in Pregnancy Outcomes
NCT05037526
not_yet_recruitingnot_applicable
The Effect of Continuous Glucose Monitoring in Individuals With Newly Diagnosed Type 2 Diabetes
NCT06471699
completednot_applicable
Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP)
NCT02074384
Clinical Trials (3)
Showing 3 of 3 trials
NCT05037526Not Applicable
Utility of Real Time Continuous Glucose Monitoring in the Care of Gestational Diabetes Versus Standard Care in Pregnancy Outcomes
NCT06471699Not Applicable
The Effect of Continuous Glucose Monitoring in Individuals With Newly Diagnosed Type 2 Diabetes
NCT02074384Not Applicable
Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP)
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3